- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05384704
A Single Group Study of Empower@Home-an Internet Cognitive Behavioral Therapy Intervention
Evaluating the Effectiveness of Empower@Home for Depression Among Older Adults
Study Overview
Status
Intervention / Treatment
Detailed Description
Depression affects up to 40% of homebound seniors but most homebound seniors do not receive psychotherapy due to various access barriers. The study team focuses on developing community-based solutions to reduce these access barriers. In a previously approved project HUM00207612, the study team tested the feasibility of a novel internet-based cognitive behavioral therapy (iCBT) program called Empower@Home. The pilot project allowed refining study procedures and the web platform used to deliver the program. In this new project, the study team will conduct a larger single group study to test the effectiveness of Empower@Home with older adults. Recruitment methods include 1) referrals from social service agencies and 2) advertisements on social media and the program website.
The intervention involves attending up to 9 pre-recorded online therapy sessions and receiving weekly coaching calls from trained research assistants for up to 10 weeks. Participants will engage in therapy in their private homes. Three assessments are scheduled, including a comprehensive baseline, a post-test, and a 10-week follow-up. Each assessment takes about 40 minutes to complete over the phone or via an online survey, depending on the participants' preference.
Subjects will be recruited from agency referrals and advertisements. Between May 2022 and Dec 2023, about 300 subjects will be recruited into a single group study design where all eligible and consented participants will receive the intervention immediately without waiting.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- ≥50 years
- have at least mild depressive symptoms, based on PHQ-9 >=5
- are willing to participate
Exclusion Criteria:
- Probable cognitive impairment based on the Blessed Orientation, Memory, and Concentration scale (score >9).
- They do not speak English
- have active suicidal ideation, defined as moderate to high risk based on the 6-item Columbia-Suicide Severity Rating Scale (C-SSRS)
- Have a terminal illness or unstable physical health with a high risk of hospitalization within the next 3 months
- Have severe vision impairment that can not be corrected and with no in-home help to assist them with using a mobile device
- possible substance use disorders as assessed by the 4-item CAGE screener (>=2 on the CAGE AND have not been sober for at least one year)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Internet-based program
Participants will be provided with access to a 9-session online program and will receive supportive remote assistance throughout regarding technical and programmatic issues.
|
The intervention is a 9-week course of internet-based cognitive behavioral therapy.
During the active intervention phase, participants will receive weekly support from a trained research staff.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Patient Health Questionnaire-9 (PHQ-9)
Time Frame: Change from Baseline PHQ-9 at 10 weeks
|
Change in 9 item standardized measures of depressive symptom severity.
PHQ-9 score ranges from 0 to 27, with a higher score indicating more severe symptoms.
|
Change from Baseline PHQ-9 at 10 weeks
|
|
Modified Treatment Evaluation Inventory
Time Frame: 10 weeks
|
11-item Likert scale relating to acceptability of program to participant modified for older adults and the study context.
The score ranges from 11 to 55, and a higher score means higher acceptability.
|
10 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Generalized Anxiety Disorder Assessment-7 (GAD-7)
Time Frame: Change from Baseline at 10 weeks
|
Change in 7-item standardized measure for severity of anxiety symptoms.
GAD7 score ranges from 0 to 21, higher score means more severe symptoms.
|
Change from Baseline at 10 weeks
|
|
Change in Duke Social Support Index (DSSI)-10
Time Frame: Change from Baseline at 10 weeks
|
Change in 10 item standardized measure for social interaction and satisfaction with social support.
Total score ranges from 10 to 30, higher score means higher social support.
|
Change from Baseline at 10 weeks
|
|
Change in PROMISE-SI
Time Frame: Change from Baseline at 10 weeks
|
Change in 8 item standardized measure for feelings of loneliness.
Total score ranges from 8 to 40, higher score means higher levels of loneliness.
|
Change from Baseline at 10 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Xiaoling Xiang, PhD, University of Michigan
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00212950
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Behavioral Symptoms
-
AccareRecruitingBehavioral Problem of Child | Behavioral DifficultiesNetherlands
-
University of MinnesotaRecruiting
-
University of AarhusInnovation Fund Denmark; TRYG Foundation; The Danish Mental Health Foundation; Aarhus...CompletedDepressive Symptoms | Anxiety Symptoms | Behavioral Problem | School AbsenteeismDenmark
-
Universidad de los Andes, ChileUniversity of TalcaRecruitingBehavioral Problem of ChildChile
-
Universidade do PortoCentro Hospitalar Universitário de São João, E.P.E.; Centro de Investigação... and other collaboratorsCompletedAnxiety | Behavioral Problem of ChildPortugal
-
Washington University School of MedicineNational Institute of Mental Health (NIMH)Active, not recruiting
-
University of Colorado, DenverNational Institute of Mental Health (NIMH); National Institutes of Health (NIH)RecruitingStress | Parenting | Irritable Mood | Behavioral ProblemUnited States
-
Fatima Jinnah Women UniversityRecruitingWell-being, Emotional and Behavioral Problems, AdolescentsPakistan
-
Central Hospital, Nancy, FranceMarie MANGEOT- Nurse; Mahmut GUNDESLI MDCompleted
-
AccareRecruitingBrief Parent Training for Children With Behavioral Difficulties in Primary Care Settings (PAINT-POH)Behavioral DifficultiesNetherlands
Clinical Trials on Empower@Home
-
University of MichiganCompletedBehavioral Symptoms | Depressive Disorder | Depression | Mood Disorders | Mental DisorderUnited States
-
University of MichiganRecruitingDepressionUnited States
-
University of MichiganNational Institute of Mental Health (NIMH); NYU Silver School of Social WorkRecruitingDepressionUnited States
-
Massachusetts General HospitalAmerican Psychological Foundation; AIM Youth Mental HealthCompletedAnxiety DisordersUnited States
-
Bio Nature HealthCitruslabsCompletedEye Health | Eye Dryness | Inflammation SymptomsUnited States
-
University of GeorgiaNational Institute of Mental Health (NIMH)Not yet recruitingHIV Pre-exposure ProphylaxisUnited States
-
University of RochesterWithdrawnHeart FailureUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
Pace UniversityNot yet recruitingChronic Disease